Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Ra Medical Systems Inc | RMED | AMEX | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.594 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.594 |
| Trades | Shares Traded | Average Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 0.5158 - 1.1675 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| - | 0 | US$ 0.594 | USD |
Ra Medical Systems Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 61.98M | 7.03M | - | 442k | -70.57M | -10.04 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Ra Medical Systems News
| Date | Time | Source | News Article |
|---|---|---|---|
| 5/03/2024 | 16:02 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 5/03/2024 | 16:01 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of.. |
| 4/02/2024 | 15:20 | Edgar (US Regulatory) | Form 8-K - Current report |
| 8/15/2023 | 15:16 | Edgar (US Regulatory) | Form 8-K - Current report |
| 8/15/2023 | 15:15 | Edgar (US Regulatory) | Form NT 10-Q - Notification of inability to timely file Form.. |
| 8/04/2023 | 15:19 | Edgar (US Regulatory) | Form 8-K - Current report |
| 7/25/2023 | 15:16 | Edgar (US Regulatory) | Form 8-K - Current report |
| 7/20/2023 | 15:26 | Edgar (US Regulatory) | Form S-8 - Securities to be offered to employees in employee.. |
| 7/14/2023 | 15:15 | Edgar (US Regulatory) | Form 8-K - Current report |
| 7/07/2023 | 15:15 | Edgar (US Regulatory) | Form 8-K - Current report |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical RMED Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 6 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Year | 1.15 | 1.1675 | 0.5158 | 0.8257834 | 373,144 | -0.556 | -48.35% |
| 3 Years | 6.36 | 7.75 | 0.11 | 1.08 | 2,396,655 | -5.77 | -90.66% |
| 5 Years | 8.70 | 9.82 | 0.11 | 2.19 | 2,489,042 | -8.11 | -93.17% |
Ra Medical Systems Description
| Ra Medical Systems Inc is a commercial-stage medical device company leveraging its laser-based platform for use in the treatment of vascular diseases. Its products restore blood-flow in arteries and clearing chronic skin conditions. The firm's products include DABRA and Pharos. DABRA System is used as a tool in the treatment of peripheral artery disease, or PAD, a form of peripheral vascular disease, which commonly occurs in the legs. Pharos is designed for use in the treatment of inflammatory skin conditions and as a tool in the treatment of psoriasis, vitiligo, atopic dermatitis, and leukoderma. |
